| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/11/1999 | CA2290749A1 Dipeptide and related compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | CA2290747A1 Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | CA2290746A1 Compounds which inhibit leukocyte adhesion mediated by vla-4 |
| 02/11/1999 | CA2239836A1 Novel arginine deiminase |
| 02/11/1999 | CA2239813A1 Novel nrdd |
| 02/11/1999 | CA2239221A1 Novel his5 |
| 02/11/1999 | CA2225185A1 Myoblast transfer therapy for relieving pain and for treating behavioral and perceptive abnormalities |
| 02/10/1999 | EP0719138B1 Iontophoretic delivery of an antimigraine drug |
| 02/10/1999 | EP0710239B1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines |
| 02/10/1999 | EP0659174B1 Derivatives of valproic and 2-valproenoic acid amides and use as anticonvulsants |
| 02/10/1999 | CN1207743A Inhibitors of interleukin-1 'beta' converting enzyme |
| 02/10/1999 | CN1207740A Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides |
| 02/10/1999 | CN1207733A Novel piperazinylalkylthiophrimidine derivs., pharmaceutical compositions contg. same and process for preparation of such compounds |
| 02/10/1999 | CN1207678A Excitatory amino acid receptor antagonists |
| 02/10/1999 | CN1207675A Sublingual and buccal administration of selegiline |
| 02/10/1999 | CN1207384A Amino compounds of 6,7,8,9-tetrahydro-cyclopenta[a]naphthalene and of 2,3-dihydro-cyclopenta[e]indene |
| 02/10/1999 | CN1207291A Use of substituted 2,4-imidazolidinedione compounds as analgesics |
| 02/10/1999 | CN1207289A Gargle capable of stopping smoking and its preparing method |
| 02/09/1999 | US5869685 Serotonin reuptake inhibitors |
| 02/09/1999 | US5869669 Reacting with an oxidizing agent in the presence of a weak acid |
| 02/09/1999 | US5869663 Intermediates for neurokinin receptor antagonists |
| 02/09/1999 | US5869537 Macrophage lipid chemoattractant |
| 02/09/1999 | US5869531 No undesireable salidiuretic properties; treating ischemia induced disorders |
| 02/09/1999 | US5869528 Administering l-carnitine or alkanoyl l-carnitine |
| 02/09/1999 | US5869509 Treat disorders responsive to openers of the large conductance calcium-activated potassium channels |
| 02/09/1999 | US5869502 Treating depression, obsessive compulsive disorder, stuttering, trichotillomania |
| 02/09/1999 | US5869499 Benzyloxyquinuclidines as substance P antagonists |
| 02/09/1999 | US5869498 Pain alleviating drug composition and method for alleviating pain |
| 02/09/1999 | US5869496 Treating asthma, emesis |
| 02/09/1999 | US5869492 Condensed thiazole derivatives, having 5-HT receptor affinity |
| 02/09/1999 | US5869486 Fused pyrimidines and pyriazines as pharmaceutical compounds |
| 02/09/1999 | US5869485 Treatment of diseases which respond to inhibition of the activity of the protein tyrosine kinase |
| 02/09/1999 | US5869480 Alleviating memory dysfunction characterized by cholinergic deficit |
| 02/09/1999 | US5869463 Use of neuro-glial cell lines for transplantation therapy |
| 02/09/1999 | US5869282 Nucleotide and protein sequences of the serrate gene and methods based thereon |
| 02/09/1999 | US5869271 G-beta-gamma regulated phosphatidylinositol-3' kinase |
| 02/09/1999 | US5869270 Single chain MHC complexes and uses thereof |
| 02/09/1999 | CA2210023C Process for the preparation of paroxetine hydrochloride anhydrate form a. |
| 02/09/1999 | CA2163274C Intermediates for producing neuroleptic perhydro-1h-pyrido¬1,2-a| pyrazines |
| 02/09/1999 | CA2084519C Method for treating alcoholism with nalmefene |
| 02/09/1999 | CA1340382C Process for the preparation of 2-arylpropionic acids |
| 02/05/1999 | CA2239817A1 Novel prokaryotic polynucleotides, polypeptides and their uses |
| 02/05/1999 | CA2239270A1 Novel phosphoribosyl transferase |
| 02/04/1999 | WO1999005272A1 Use of transcription factor brn-3a |
| 02/04/1999 | WO1999005147A1 Thiazolobenzoheterocycles, preparation and medicines containing same |
| 02/04/1999 | WO1999005142A1 Novel compounds |
| 02/04/1999 | WO1999005134A1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 02/04/1999 | WO1999005121A1 Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments |
| 02/04/1999 | WO1999005113A1 Substituted 6-phenylphenanthridines |
| 02/04/1999 | WO1999005112A1 Substituted 6-alkylphenanthridines |
| 02/04/1999 | WO1999005111A1 Novel tetrazole derivatives |
| 02/04/1999 | WO1999005095A1 Aminocycloalkane compounds |
| 02/04/1999 | WO1999004786A1 Inhibitor and therapeutic agent for brain aging |
| 02/04/1999 | WO1999004785A1 Use of alkanoyl carnitine derivatives for the treatment of attention-deficit/hyperactive disorders |
| 02/04/1999 | WO1999004782A1 Therapeutic and dietary compositions containing essential fatty acids and bioactive disulphides |
| 02/04/1999 | WO1999004779A1 Pharmaceutical formulation comprising a 2-aminoacetamide derivative and an ion exchange resin |
| 02/04/1999 | WO1999004778A1 Pharmaceutical compounds |
| 02/04/1999 | WO1999004775A2 Method of treating dopaminergic and gaba-nergic disorders |
| 02/04/1999 | WO1999004771A2 Use of levobupivacaine |
| 02/04/1999 | WO1999004765A2 Pharmaceutical compositions containing an effervescent acid-base couple |
| 02/04/1999 | WO1998048821A3 Use of conantokins for producing analgesia or for neuroprotection |
| 02/04/1999 | CA2298107A1 Use of transcription factor brn-3a |
| 02/04/1999 | CA2297923A1 Novel tetrazole-substituted 6-phenyl-pheanathridines as pde inhibitors |
| 02/04/1999 | CA2297906A1 Pharmaceutical compounds |
| 02/04/1999 | CA2297410A1 Method of treating dopaminergic and gaba-nergic disorders |
| 02/04/1999 | CA2296648A1 Novel compounds |
| 02/04/1999 | CA2296518A1 Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 02/04/1999 | CA2296329A1 Aminocycloalkane compounds |
| 02/03/1999 | EP0894863A1 A YAK-1 related serine/threonine protein kinase-HTLAR33 |
| 02/03/1999 | EP0894855A2 Human I kappa B-beta transcription factor |
| 02/03/1999 | EP0894854A2 A novel splicing variant of the epstein-barr virus-induced g-protein coupled receptor |
| 02/03/1999 | EP0894796A1 Imidazolines substituted with a heterocyclic ring as alpha-2 antagonists |
| 02/03/1999 | EP0894497A1 Use of substituted imidazolidin-2,4-diones as analgesics |
| 02/03/1999 | EP0894144A2 Diagnosing trinucleotide repeat diseases and genes involved therein |
| 02/03/1999 | EP0894093A2 Soluble tachykinin antagonists, the preparation and use thereof |
| 02/03/1999 | EP0894085A1 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors |
| 02/03/1999 | EP0894010A2 Denaturants for sympathomimetic amine salts |
| 02/03/1999 | EP0894004A1 Methods for enhancing functional recovery following central nervous system ischemia or trauma |
| 02/03/1999 | EP0893997A1 Paroxetine in treatment of depression |
| 02/03/1999 | EP0763038B1 The preparation of nalbuphine having low levels of beta-epimer |
| 02/03/1999 | EP0652747B1 Controlled release morphine preparation |
| 02/03/1999 | EP0510186B1 Therapeutic uses of melanin |
| 02/03/1999 | CN1207100A Novel indole-2,3-done-3-oxime derivatives |
| 02/03/1999 | CN1207043A Inhibitors of cyclophilin rotamase activity |
| 02/03/1999 | CN1206712A Heterocyclic compound, preparation process thereof and medicinal composition containing same |
| 02/03/1999 | CN1206589A Process for preparing medicine composition |
| 02/03/1999 | CN1041935C Benzo [f] quinoxalindione derivative, their use in medicine |
| 02/03/1999 | CN1041931C [1,2,4] trizolo [4,3,-a] quinoxaline compounds, their preparation and use |
| 02/03/1999 | CN1041930C [1,2,4] triazolo [4,3-1] quinoxaline derivatives, their preparation and use |
| 02/03/1999 | CN1041928C Imidazoloquinoxalinone and preparation process and use thereof |
| 02/03/1999 | CN1041923C Piperzine derivatives and preparation process and usage thereof |
| 02/02/1999 | US5866703 With at least two different acids chosen from 6-desaturated essential fatty acids and oleic acid, useful in nutrition and in medicine. |
| 02/02/1999 | US5866702 Purine inhibitors of cyclin dependent kinase 2 |
| 02/02/1999 | US5866693 Detecting mutations in the polynucleotides encoding the madr3 or madr4 and for detecting altered levels of the polypeptide in a host. |
| 02/02/1999 | US5866586 CNS-active pyridinylurea derivatives |
| 02/02/1999 | US5866581 Penciclovir for the treatment of post therapeutic neuralgia |
| 02/02/1999 | US5866578 Substituted pyrimidines for control of diabetic complications |
| 02/02/1999 | US5866566 Derivatives of 10, 11-Dihydro-10-OXO-5H-Dibenz/B,F/Azepine-5-carboxamide |
| 02/02/1999 | US5866565 Substituted-4-amino-3-pyridinols |
| 02/02/1999 | US5866551 Therapy for atherosclerosis |